Fig. 1: Bright field performance and growth characteristics of GC organoids.
From: Establishment of gastric signet ring cell carcinoma organoid for the therapeutic drug testing
A The growth of gastric SRCC (G06) and non-SRCC (G14) organoids under different magnifications. Scale bars, 100 μm. B The growth process of SRCC (G06) and non-SRCC (G04) organoids. Scale bars, 100 μm. C The characteristics of long-term culture of SRCC (G20) and non-SRCC (G16) organoids. Scale bars, 100 μm. D Bright field appearance of SRCC (G06, G20) and non-SRCC (G08, G18) organoids before cryopreservation and after resuscitation. E The appearance of SRCC (G20) and non-SRCC (G04) organoids under the electron microscope. F Comparison of cell doubling times, four SRCCs and eight non-SRCC organoid lines. Data are presented as the mean ± SD. *p < 0.05.
